Eurofins Scientific acquires the food and pharma testing services of ILS

Published: 17-Nov-2016
Finance Analysis

Latest acquisition reinforces Eurofins' commitment to the food and pharmaceutical testing services industry in the UK and Ireland


Eurofins Scientific has acquired ILS, one of the largest independent suppliers of contract laboratory services in the UK. ILS offers a comprehensive range of chemistry and microbiological testing to the pharmaceutical, food, environmental and consumer product industries. The purchase follows Eurofins' acquisition of Exova's food, pharmaceutical and water testing laboratories in July.

Eurofins Scientific is a leader in food, environment and pharmaceutical products testing, as well as agroscience, genomics, discovery pharmacology and central laboratory services. In addition, the company is one of the key emerging players in speciality clinical diagnostic testing in Europe and the US.

A transition process is now underway to bring the ILS team into the Eurofins family. During this transitional period, any work currently in progress or any new work undertaken will continue to be performed by the existing ILS teams. It is not expected that there will be any disruption to services during this period.

See more

You may also like

Finance

Eurofins agrees to acquire TestAmerica

Read more
The agreed acquisition price is US$175 million on a cash free debt free basis. Transaction is expected to close in the fourth quarter of 2018

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Integrity testing of HEPA filters: A practical approach Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit for purpose once installed in your facility
  2. Syntegon launches new "Settle Plate Changer" for automated viable monitoring Syntegon has patented its new Settle Plate Changer (SPC) for automated viable monitoring in the aseptic filling process
  3. Validation of contact plates for environmental monitoring Merck KGaA, Darmstadt, Germany, the life sciences company, provides a case study of supplier validation to help prevent contamination in aseptic manufacturing areas
  4. Scientific justification for monitoring indirect product contact surfaces Findings from a survey on several pharma companies unveil the best practices for monitoring indirect product contact surfaces. Walid El Azab and Lillia Belkhamassi explain
  5. Microbiological monitoring: Adapting to new rapid methods regulatory demands Dr Wan Li Low from Cherwell takes a look at the shift towards Rapid Microbiology Methods (RMM) and their validation

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Finance

Eurofins agrees to acquire TestAmerica

The agreed acquisition price is US$175 million on a cash free debt free basis. Transaction is expected to close in the fourth quarter of 2018
Finance

Eurofins acquires Wisconsin-based food testing company

The acquisition of Covance Food Solutions strengthens Eurofins’ food testing offering in the US
Analysis

Eurofins acquires food testing laboratory in France

The bioanalytical testing company has acquired Laboratoire de Bromatologie de l’Ouest
Finance

Eurofins expands testing, inspection and certification operations

Global lab has acquired two subsidiaries of the Finnish research centre VTT Group
Manufacturing

Eurofins opens new facility in Livingston, Scotland

Eurofins Scientific, a global provider of bioanalytical testing, has today opened the new pharmaceutical chemistry, microbiology and water microbiology facility in Livingston following a £4 million investment
Analysis

Eurofins to invest millions in new UK facility

The testing company will be able to provide a range of GMP pharmaceutical testing services
Design & Build

Eurofins Lancaster Labs to grow its lab services footprint

With an expanded campus the company aims to increase its workforce in bio/pharmaceutical analysis to 500 plus by 2021
Subscribe now